BRYLEOS
Live / Applied — Fourth extension granted (statement of use) (as of 04 Mar 2026)
What this means for you
Not registered yet, but its 13 Dec 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97715158
- Mark type
- Stylized text
- Filed
- 13 Dec 2022
- Published for opposition
- 07 Nov 2023
- Attorney of record
- Aaron Chaloner
Goods and services
- Class 001 — Chemicals: Chemicals for use in agriculture, horticulture, and botany, except fungicides, herbicides, insecticides, and parasiticides; Chemical preparations for use in agriculture, horticulture, and botany, namely, chemical preparations for managing growth, health, and sustainability of plants except fungicides, herbicides, insecticides, and parasiticides; Substances for regulating growth in plants; Chemical preparations to prevent and treat diseases affecting rooted plants
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for humans and animals for the prevention and treatment of neurologic, cardiovascular, dermatologic, inflammatory, immunologic, neuromuscular, reproductive, pancreatic, metabolic, hepatic, inflammatory, psychiatric, and orthopedic diseases, disorders, and conditions; Pharmaceutical preparations for humans and animals for the prevention and treatment of substance use disorder and substance withdrawal; Pharmaceutical preparations for humans and animals for use in treating and managing diseases, disorders, and conditions relating to aging; Therapeutic preparations for humans and animals, namely, therapeutic pharmaceutical preparations for the treatment and prevention of intracellular NAD depletion; Therapeutic preparations for humans and animals, namely, therapeutic pharmaceutical preparations for replenishing coenzyme depletion; Therapeutic agents for humans and animals for regulation of gene expression in aging and metabolic disease, nutrient sensing, and inflammasome suppression
- Class 042 — Scientific and technological services: Research and development in the fields of human and veterinary pharmaceuticals, intracellular NAD depletion, aging, and aging-related diseases, disorders, and conditions for humans and animals; Providing medical scientific information in the fields of human and veterinary pharmaceuticals, intracellular NAD depletion, aging, and aging-related diseases, disorders, and conditions for humans and animals
Owner
- BioNADrx Holdings, Inc., Johnson City, TN, US
- BioNADrx Holdings, Inc., Johnson City, TN, US
Prosecution history
- 05 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Mar 2026 — SOU EXTENSION 4 GRANTED
- 02 Jan 2026 — SOU EXTENSION 4 FILED
- 04 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Feb 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 04 Feb 2026 — NOTICE OF REVIVAL - E-MAILED
- 04 Feb 2026 — PETITION TO REVIVE-GRANTED
- 04 Feb 2026 — TEAS PETITION TO REVIVE RECEIVED
- 02 Feb 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 02 Feb 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 12 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 12 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 24 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jun 2025 — SOU EXTENSION 3 GRANTED